mitomycin has been researched along with Cirrhosis, Liver in 14 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1-Hexylcarbamoyl-5-fluorouracil (HCFU) was orally administered at doses of 300-600 mg daily for 7-360 days to 27 inoperable cirrhotics with hepatocellular carcinoma." | 7.67 | [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma]. ( Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y, 1984) |
| "Survival period of 28 cases with unresectable hepatocellular carcinoma treated with transhepatic arterial one-shot infusion of 30 mg mitomycin C (MMC) were retrospectively reviewed from the standpoint of hepatic angiographic findings, scintigraphic existence of liver cirrhosis and changes of AFP value." | 7.66 | [Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C]. ( Kobayashi, H, 1982) |
| "From 1986 to 1988, 35 patients with a hepatoma judged either inoperable or unresectable because of coexistent cirrhosis were treated with hepatic arterial embolization of mitomycin C microcapsules." | 5.28 | Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. ( Audisio, RA; Bellegotti, L; Damascelli, B; DeFazio, C; Doci, R; Marchianò, A; Mazzaferro, V; Montalto, F; Piva, A; Tommasini, M, 1990) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "1-Hexylcarbamoyl-5-fluorouracil (HCFU) was orally administered at doses of 300-600 mg daily for 7-360 days to 27 inoperable cirrhotics with hepatocellular carcinoma." | 3.67 | [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma]. ( Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y, 1984) |
| "Survival period of 28 cases with unresectable hepatocellular carcinoma treated with transhepatic arterial one-shot infusion of 30 mg mitomycin C (MMC) were retrospectively reviewed from the standpoint of hepatic angiographic findings, scintigraphic existence of liver cirrhosis and changes of AFP value." | 3.66 | [Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C]. ( Kobayashi, H, 1982) |
| "Thirty-six hepatocellular carcinoma patients not indicated for surgical resection underwent super- selective transcatheter arterial chemoembolization, divided into small dose (n=15) and conventional dose (n=21) chemotherapy groups." | 1.38 | Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses. ( Hu, Y; Li, H; Li, N; Zhou, Y, 2012) |
| "From 1986 to 1988, 35 patients with a hepatoma judged either inoperable or unresectable because of coexistent cirrhosis were treated with hepatic arterial embolization of mitomycin C microcapsules." | 1.28 | Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. ( Audisio, RA; Bellegotti, L; Damascelli, B; DeFazio, C; Doci, R; Marchianò, A; Mazzaferro, V; Montalto, F; Piva, A; Tommasini, M, 1990) |
| "Fourty eight patients with cancer of head of pancreas have been treated by the intra-arterial infusion of 5-FU and Mitomycin C alone or in combination with regional hyperthermia, employing microwave machine operating at a frequency of 2450 MHz." | 1.27 | [Hyperthermia: microwave hyperthermia in combination with intra-arterial infusion chemotherapy of cancer of the pancreas]. ( Endo, Y; Funatomi, H; Hatta, Y; Hirose, N; Miura, T; Sassa, T; Taguchi, S; Yoshikawa, N, 1985) |
| "Twenty-two patients with hepatocellular carcinoma were treated with transcatheter arterial embolization therapy." | 1.27 | [Retrospective study of short survival cases in hepatocellular carcinoma after transcatheter arterial embolization therapy]. ( Fujii, H; Iwai, M; Miyoshi, M; Suyama, Y, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, EJ | 1 |
| Chin, R | 1 |
| Nachbur, U | 1 |
| Silke, J | 1 |
| Jia, Z | 1 |
| Angus, PW | 1 |
| Torresi, J | 1 |
| Li, H | 1 |
| Hu, Y | 1 |
| Li, N | 1 |
| Zhou, Y | 1 |
| Akiharu, W | 1 |
| Higashi, T | 1 |
| Kobayashi, M | 1 |
| Nakatsukasa, H | 1 |
| Fujiwara, M | 1 |
| Shiota, T | 1 |
| Yamauchi, Y | 1 |
| Ito, T | 1 |
| Yamamoto, H | 1 |
| Nagashima, H | 1 |
| Kobayashi, H | 1 |
| Kato, S | 1 |
| Onda, M | 1 |
| Tokunaga, A | 1 |
| Yoshiyuki, T | 1 |
| Matsukura, N | 1 |
| Kim, DY | 1 |
| Tajiri, T | 1 |
| Yamashita, K | 1 |
| Solomon, B | 1 |
| Soulen, MC | 1 |
| Baum, RA | 1 |
| Haskal, ZJ | 1 |
| Shlansky-Goldberg, RD | 1 |
| Cope, C | 1 |
| Kakumu, S | 1 |
| Ito, S | 1 |
| Ishikawa, T | 1 |
| Mita, Y | 1 |
| Tagaya, T | 1 |
| Fukuzawa, Y | 1 |
| Yoshioka, K | 1 |
| Furukawa, H | 1 |
| Hara, T | 1 |
| Taniguchi, T | 1 |
| Matsuda, H | 1 |
| Audisio, RA | 1 |
| Doci, R | 1 |
| Mazzaferro, V | 1 |
| Bellegotti, L | 1 |
| Tommasini, M | 1 |
| Montalto, F | 1 |
| Marchianò, A | 1 |
| Piva, A | 1 |
| DeFazio, C | 1 |
| Damascelli, B | 1 |
| Miura, T | 1 |
| Hatta, Y | 1 |
| Endo, Y | 1 |
| Sassa, T | 1 |
| Yoshikawa, N | 1 |
| Hirose, N | 1 |
| Funatomi, H | 1 |
| Taguchi, S | 1 |
| Adachi, S | 1 |
| Todoroki, T | 1 |
| Ishikawa, A | 1 |
| Nosue, M | 1 |
| Fukao, K | 1 |
| Iwasaki, Y | 1 |
| Saida, Y | 1 |
| Yamaguchi, T | 1 |
| Osuga, T | 1 |
| Doi, M | 1 |
| Suyama, Y | 1 |
| Iwai, M | 1 |
| Fujii, H | 1 |
| Miyoshi, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Humanitarian Device Exemption Use Protocol of Therasphere® for Treatment of Unresectable Hepatocellular and Metastatic Liver Tumors - HDE #980006[NCT00701168] | 0 participants | Expanded Access | No longer available | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for mitomycin and Cirrhosis, Liver
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
1 trial available for mitomycin and Cirrhosis, Liver
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
13 other studies available for mitomycin and Cirrhosis, Liver
| Article | Year |
|---|---|
Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; | 2015 |
Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2012 |
[Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; C | 1984 |
[Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C].
Topics: Adult; Aged; alpha-Fetoproteins; Angiography; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular | 1982 |
[Mitomycin C-DNA adduct detection in rat organs and human liver].
Topics: Adult; Animals; Carcinoma, Hepatocellular; DNA Adducts; Female; Humans; Liver; Liver Cirrhosis; Live | 1996 |
Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population.
Topics: alpha-Fetoproteins; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chem | 1999 |
Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Dendritic Ce | 2000 |
[Comparative changes in hepatic function induced by transhepatic arterial chemoimmunoembolization among liver cancer patients].
Topics: Chemoembolization, Therapeutic; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Cirr | 1992 |
[Serial changes in serum levels of laminin and type III procollagen N-terminal peptide after transarterial embolization (TAE) in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1991 |
Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis.
Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Delayed-Action Preparations; Embolizatio | 1990 |
[Hyperthermia: microwave hyperthermia in combination with intra-arterial infusion chemotherapy of cancer of the pancreas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Hepatocellular; Combined | 1985 |
[Transcatheter arterial infusion therapy using lipiodol and mitomycin C for hepatocellular carcinoma with liver cirrhosis].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Humans; Infusions, Intr | 1988 |
[Retrospective study of short survival cases in hepatocellular carcinoma after transcatheter arterial embolization therapy].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Gelatin Sponge, Absorbable; Human | 1985 |